Total:12
-
2026-10-18 15:03
Royan Intl. Twin Congress slated for September 2027
TEHRAN – Tehran will play host to the Royan International Twin Congress, including the 28th Congress on Reproductive Biomedicine, the 23rd Congress on Stem Cell Biology and Technology, and the 22nd seminar on Nursery and Midwifery, from September 1-3, 2027.
-
2026-09-22 16:15
Royan Institute findings highlight MSCs’ potential for cell-based ASD therapy
TEHRAN – Researchers from Royan Institute, in a study, have managed to lower the Childhood Autism Rating Scale (CARS) scores and certain inflammatory biomarkers in children with autism spectrum disorder (ASD) using allogeneic mesenchymal stromal cells (MSCs) derived from umbilical cord Wharton’s jelly.
-
2026-09-18 15:09
Royan Institute achieves global milestone in regenerative medicine with WhartoCell
TEHRAN – Iran has taken a major step forward in regenerative medicine with the approval of WhartoCell, an allogeneic stem cell therapy developed by researchers at Royan Institute to treat osteoarthritis.
-
2026-09-12 16:18
Webinar on fertility preservation for people over 30 set for October
TEHRAN – Royan Institute will host a specialized webinar on October 1 to help individuals make informed decisions about their reproductive health, focusing on fertility preservation options and strategies for single women and men over 30.
-
2026-09-04 14:55
Tehran plays host to Royan Intl. Twin Congress
TEHRAN – The Royan International Twin Congress, including the 27th Congress on Reproductive Biomedicine, the 22nd Congress on Stem Cell Biology and Technology, and the 21st seminar on Nursery and Midwifery, was held from Wednesday to Friday.
-
2026-08-16 15:39
Royan hosting intl. event on role of microbiome in regenerative medicine
TEHRAN - The Royan Institute is playing host to the 17th International Summer School in Tehran to examine the growing role of the microbiome in regenerative medicine.
-
2026-08-09 19:52
NamiRa: Iranian-developed manually curated microRNA database on cancers
TEHRAN – Iranian researchers at Royan Institute, in collaboration with researchers from Germany’s University of Duisburg-Essen, have developed namiRa (meaning “immortal” in Persian), a comprehensive and specialized database that serves as a valuable scientific infrastructure that facilitates the identification of novel cancer biomarkers, accelerates the discovery of therapeutic targets, and supports the design of future cancer research.
-
2026-08-07 16:08
Royan Institute marks significant achievement in pediatric oncofertility
TEHRAN – Three years into the treatment of two young girls diagnosed with Ewing sarcoma, Royan Institute has showcased its commitment to integrating reproductive health into modern oncology practice, marking a significant achievement in pediatric oncofertility.
-
2026-08-04 15:18
Royan Institute, Kazakhstan NCB agree to develop sci-tech co-op
TEHRAN – Royan Institute and the Kazakhstan National Center for Biotechnology (NCB) have explored the potential to expand joint efforts, agreeing to enhance educational, research, and technological cooperation and implement joint research projects.
-
2026-05-22 16:33
Infertility treatment offered to couples from Australia, England, Iraq, Afghanistan, and Pakistan
TEHRAN – Couples from Australia, England, Iraq, Afghanistan, and Pakistan have received infertility treatment at Royan Institute in the current Iranian calendar year, which started on March 21.
-
2026-04-26 16:46
Royan Institute extends abstract submission deadline to Intl. Twin Congress
TEHRAN – The deadline for the submission of abstracts of the articles to the Royan International Twin Congress, which is planned to be held in Tehran from September 2 to 4, has been extended from April 20 to May 21, IRNA reported.
-
2026-01-18 15:31
Royan Intl. Twin Congress slated for September
TEHRAN – Royan International Twin Congress, the 27th Congress on Reproductive Biomedicine, the 22nd Congress on Stem Cell Biology and Technology, and the 21st Seminar on Nursery and Midwifery, are scheduled to be held in Tehran from September 2 to 4.